Skip to main content

Table 4 Quality of life at T5

From: Effects of structured involvement of the primary care team versus standard care after a cancer diagnosis on patient satisfaction and healthcare use: the GRIP randomised controlled trial

 

Intervention (N = 59)

Mean (SD)

Control (N = 69)

Mean (SD)

Between group1 -

Mean diff. (95% CI)

Function scales

 Physical Function

78.8 (22.1)

81.5 (18.4)

−0.5 (−6.0;4.9)

 Role Function

70.6 (31.0)

75.4 (28.4)

−4.6 (− 14.7;5.5)

 Emotional Function

80.4 (22.6)

79.8 (23.5)

−1.7 (−9.4;6.1)

 Cognitive Function

79.4 (23.8)

77.3 (24.9)

3.2 (− 4.7;11.2)

 Social Function

79.7 (25.0)

78.7 (28.9)

−1.2 (− 10.6;8.1)

Symptom scales

 Fatigue

31.3 (27.2)

32.9 (27.4)

−2.0 (−10.8;6.9)

 Nausea/vomiting

2.8 (9.9)

2.9 (8.1)

−0.2 (−3.4;3.0)

 Pain

23.7 (30.5)

20.5 (24.4)

2.1 (−7.0;11.3)

Single items

 Dyspnoea

13.6 (24.9)

12.1 (24.9)

2.2 (−4.1;8.5)

 Insomnia

30.5 (34.1)

28.0 (31.1)

2.2 (−8.0;12.4)

 Appetite loss

4.0 (12.5)

8.2 (20.9)

−4.4 (−10.1;1.3)

 Constipation

10.2 (25.0)

5.8 (16.1)

2.7 (−4.5;9.8)

 Diarrhoea

5.7 (19.7)

7.7 (19.9)

−1.6 (−8.7;5.5)

 Financial difficulties

7.9 (17.9)

11.6 (24.1)

−4.1 (−11.7;3.6)

Global scales

 Global Quality of life

71.9 (19.1)

72.6 (20.5)

−1.2 (−7.6;5.3)

 Summary functioning scale

82.1 (17.0)

82.7 (15.5)

−0.4 (−5.4;4.6)

  1. 1 Adjusted for stratification factors and baseline
  2. Abbreviations: CI Confidence Interval, SD Standard Deviation